MoneyWorks4Me

Dr Reddy's Laboratories informs about press release

16 Dec 2022 Evaluate
Dr Reddy's Laboratories has informed that Aurigene Oncology, a wholly owned subsidiary of Dr Reddy's Laboratories, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis. A press release in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1841.40
Dr. Reddys Labs. 1145.80
Cipla 1355.60
Lupin 2053.00
Zydus Lifesciences 1101.95
View more..